Show results for
Refine by
Immune Response Suppliers Serving Morocco
178 companies found
based inDallas, TEXAS (USA)
Vaxxinity is a U.S.-based global biotechnology company pioneering a new class of medicines to democratize health. Headquartered in Dallas, TX, with operations in the United States, Latin America, Europe and Asia, the company’s proprietary technology ...
Our Vaxxine Platform is designed to harness the immune system to convert the body into its own natural “drug factory” stimulating the production of antibodies. Our technology uses synthetic peptides to mimic and ...
based inMarseille Cedex 9, FRANCE
Veracyte, formerly HalioDx, is a global diagnostics company that improves patient care by answering important clinical questions to inform diagnosis and treatment decisions throughout the patient journey in cancer and other diseases. Our ...
Designed to deliver critical information to guide chemotherapy decision-making, Immunoscore® can be used in Stage II localized colon cancer to help physicians identify patients who may be spared adjuvant chemotherapy, and in Stage III ...
based inAtlanta, GEORGIA (US) (USA)
Micron develops pharmaceutical products, based on its proprietary microneedle patch technology, that are designed to provide enhanced vaccines and proprietary drugs efficacy, superior patient compliance, and simplified administration, distribution, ...
Micron’s “peel & stick” microneedle patch is applied simply by pressing it against the skin, like a BAND-AID®. This simple and minimally-invasive approach eliminates pain and fear associated with injections and allows ...
based inWürzburg, GERMANY
Toleris Biotherapeutics GmbH is a biotechnology company based in Würzburg, Germany. The company specializes in the development of innovative biotherapeutic solutions aiming to advance the field of medicine through cutting-edge scientific research. ...
AIM Bio has developed a platform of Autoimmunity Modifying Biologicals (AIM Biologicals) that uses soluble, near-physiological proteins to induce selective, antigen-specific immune tolerance. These proteins mimic a natural process ...
based inBalerna, SWITZERLAND
APR Applied Pharma Research s.a. (APR) is a Swiss Pharma company dedicated to providing patients suffering from rare diseases with innovative treatments that make a real difference in their life. Our focus as a Swiss global health care company is ...
Nexodyn® AcidOxidizing Solution (AOS) is the Tehclo™ based wound care solution proven to restart healing in stalled wounds.2,6 A wealth of evidence and real-world experience consistently show accelerated closure1 with reduced infection ...
based inDuluth, GEORGIA (US) (USA)
The products that make up the BIVI portfolio help animals feel better, perform better and live better. A guiding principle of the Boehringer family has always been to provide Value through Innovation to our customers. We strive to provide our ...
based inWuhan, CHINA
Mulei (Wuhan) New Material Technology Co. Ltd is a scientific and technological company integrating product research and development manufacturing and trading of chemical intermediates, specialized in organic intermediates, pharmaceutica ...
Common Name: Levamisole (hydrochloride). CAS Number: 16595-80-5. Molecular Weight: 240.752. Boiling Point: 344.4°C at 760 mmHg. Molecular Formula: C11H13CIN2S. Melting Point: 226-231°C. Flash Point: ...
based inAuburn, ALASKA (USA)
SiO2 Materials Science is focused on three core segments: Pharmaceuticals, Molecular Diagnostics, and Consumer Healthcare. In the pharma segment, we solve more than 30 problems including some of the most challenging related to drug stability, drug ...
We provide a common drug contact surface starting at the research and pre-clinical drug development phases, through clinical trials, and on through to commercial ...
based inWoburn, MASSACHUSETTS (USA)
We are an investigational-stage infectious disease company focused on combating all diseases resulting from herpes simplex virus 1 (HSV-1) and herpes simplex virus 2 (HSV-2) infections. Using our proprietary technology, we are developing rationally ...
One of the most celebrated achievements of modern medicine is the eradication of the smallpox virus with the use of a live-attenuated vaccine. We are advancing the applied science of attenuating live viruses to develop an entirely new class of ...
based inCarlton South, AUSTRALIA
Chimeric Therapeutics is a clinical stage cell therapy company focused on bringing the promise of cell therapy to life for more patients with cancer. We believe that cellular therapies have the promise to cure cancer not just delay disease ...
T cells are part of our adaptive immune system – the system that tailors the body’s response to specific pathogens. Rather than generically attack any antigens, T cells circulate until they encounter a ...
based inDreieich, GERMANY
Biotest - innovation in haematology, clinical immunology and intensive care medicine. Biotest is a specialist in innovative haematology, clinical immunology and intensive care medicine. Biotest develops, manufactures and markets plasma proteins and ...
Trimodulin is an innovative polyvalent antibody composition, purified from human plasma. In comparison to standard IgG preparations (IVIG), trimodulin contains relevant amounts of IgM and IgA in addition to ...
based inLancaster, CALIFORNIA (USA)
Simulations Plus provides cutting-edge software solutions and consulting services designed to enhance drug discovery, clinical development, and regulatory submission processes. With over 25 years of experience, the company has established itself as ...
DILIsym integrates compound exposure with mechanisms of drug toxicity and inter-individual variability, offering insights into hepatotoxicity prediction for multiple species, including mice, rats, dogs, and humans. Its comprehensive sub-models cover ...
based inMeinier, SWITZERLAND
Infomed is a Swiss company based in Geneva dedicated to the development and manufacturing of blood purification devices since 1997. Our products are applicable to nephrology, intensive care, hematology and cardiology. Infomed has been, for more than ...
based inAddison, TEXAS (USA)
VITRUVIAN BioMedical, Inc is a biotechnology company focused on a unique Business Strategy based on Early, Medium and Late Stage product development. We are committed to providing 'Advance Personalized Medicine' to medical professionals and patients ...
VITRUVIAN has obtained the Exclusive Global License for a Therapeutic Vaccine for the Prevention of Alzheimer's Disease. YM7555 - Alzheimer’s Disease Therapeutic Vaccine targeting ABeta and TAU. VITRUVIAN has received an Exclusive Global ...
based inLyon Cedex 7, FRANCE
EPISKIN, world leader in tissue engineering, offers Human Reconstructed Tissues to the global scientific community - academic and industry - to support research and development activities in Safety and Efficacy. We provide our worldwide clients ...
They are mostly located and evenly spread within the supra-basal epidermal layer. The SkinEthic™ RHE-LC model is therefore expected to be a useful tool for skin immune response studies. ...
based inWest Sussex, UNITED KINGDOM
We are a market leading, pioneering immunology business with specialist experience in the research and development of allergy treatments. We believe that transformational outcomes for patients are achieved by directly treating the cause, rather than ...
based inSeattle, WASHINGTON (USA)
AVM Biotechnology is developing and advancing AVM0703, a proprietary formulation of concentrated dexamethasone. This formulation permits the very high dosing necessary to activate the release and trigger the production of the body’s supercharged ...
Most people who get ARDS are already at the hospital for trauma or illness. Lung injuries can occur from trauma, an overwhelming immune response due to an infection, allergic reaction or a cell/gene therapy product ...
based inMaidenhead, UNITED KINGDOM
As a global leader in influenza protection, CSL Seqirus has one of the broadest influenza vaccine portfolios in the world. In the Asia Pacific region we also provide access to a wide range of vaccines and specialty medicines that meet unique, local ...
As a global leader in influenza protection, Seqirus has one of the broadest influenza vaccine portfolios in the world. In the Asia Pacific region we also provide access to a wide range of vaccines and specialty medicines that meet unique, local ...
based inSouth Melbourne, AUSTRALIA
BioDiem is an Australian biopharmaceutical company that is focused on developing and commercialising vaccines and infectious disease therapies. Our business model is to generate income from partnerships including with other vaccine and infectious ...
A core technology advantage: Live Attenuated Influenza Virus (LAIV) vaccine. BioDiem’s lead asset is the Live Attenuated Influenza Virus (LAIV) vaccine technology. Our LAIV vaccine licensing business involves out-licensing of the ...
based inDidcot, UNITED KINGDOM
We design, develop and manufacture nanofibrous biomaterials for medical devices and regenerative medicine. Our technology platform is built on electrospinning and associated processing technologies. We are supporting clients with material ...
The advantages of electrospinning are the ability to tailor polymer, architecture and structure to create nanofibre and microfibre materials suitable for different therapeutic ...